Related references
Note: Only part of the references are listed.Mild behavioral impairment: measurement and clinical correlates of a novel marker of preclinical Alzheimer's disease
Byron Creese et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Considerations regarding a diagnosis of Alzheimer's disease before dementia: a systematic review
Jetske van der Schaar et al.
ALZHEIMERS RESEARCH & THERAPY (2022)
Bringing Alzheimer Disease Testing and Results Disclosure Into the 21st Century Cures Act
Emily A. Largent et al.
JAMA NEUROLOGY (2022)
The Alzheimer's Association appropriate use recommendations for blood biomarkers in Alzheimer's disease
Oskar Hansson et al.
ALZHEIMERS & DEMENTIA (2022)
Disclosing Alzheimer Disease Biomarker Results to Research Participants
Joshua D. Grill et al.
JAMA NEUROLOGY (2022)
Clinical impact of18F-FDG-PET among memory clinic patients with uncertain diagnosis
Giulia Perini et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2021)
The Future Is P-Tau-Anticipating Direct-to-Consumer Alzheimer Disease Blood Tests
Emily A. Largent et al.
JAMA NEUROLOGY (2021)
Family members' perspectives on learning cognitively unimpaired older adults' amyloid-β PET scan results
Emily A. Largent et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2021)
Ethical Considerations in Dementia Diagnosis and Care AAN Position Statement
Winston Chiong et al.
NEUROLOGY (2021)
Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers
J. Scott Roberts et al.
ALZHEIMERS & DEMENTIA-TRANSLATIONAL RESEARCH & CLINICAL INTERVENTIONS (2021)
'That would be dreadful': The ethical, legal, and social challenges of sharing your Alzheimer's disease biomarker and genetic testing results with others
Emily A. Largent et al.
JOURNAL OF LAW AND THE BIOSCIENCES (2021)
Disclosure of preclinical Alzheimer's disease biomarker results in research and clinical settings: Why, how, and what we still need to know
Claire M. Erickson et al.
ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING (2021)
Cognitively unimpaired adults' reactions to disclosure of amyloid PET scan results
Emily A. Largent et al.
PLOS ONE (2020)
A randomized controlled trial of amyloid positron emission tomography results disclosure in mild cognitive impairment
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2020)
Short-term Psychological Outcomes of Disclosing Amyloid Imaging Results to Research Participants Who Do Not Have Cognitive Impairment
Joshua D. Grill et al.
JAMA NEUROLOGY (2020)
The Rise of Pseudomedicine for Dementia and Brain Health
Joanna Hellmuth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Association of Amyloid Positron Emission Tomography With Subsequent Change in Clinical Management Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia
Gil D. Rabinovici et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The Proactive Patient: Long-Term Care Insurance Discrimination Risks of Alzheimer's Disease Biomarkers
Jalayne J. Arias et al.
JOURNAL OF LAW MEDICINE & ETHICS (2018)
NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease
Clifford R. Jack et al.
ALZHEIMERS & DEMENTIA (2018)
Comprehension of an Elevated Amyloid Positron Emission Tomography Biomarker Result by Cognitively Normal Older Adults
Jessica Mozersky et al.
JAMA NEUROLOGY (2018)
Study partners: essential collaborators in discovering treatments for Alzheimer's disease
Emily A. Largent et al.
ALZHEIMERS RESEARCH & THERAPY (2018)
Amnestic MCI patients' experiences after disclosure of their amyloid PET result in a research context
Gwendolien Vanderschaeghe et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Communicating mild cognitive impairment diagnoses with and without amyloid imaging
Joshua D. Grill et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Patient and caregiver reactions to clinical amyloid imaging
Joshua D. Grill et al.
ALZHEIMERS & DEMENTIA (2017)
Development of a Standardized Approach to Disclosing Amyloid Imaging Research Results in Mild Cognitive Impairment
Jennifer H. Lingler et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Predictive Testing for Alzheimer's Disease Suicidal Ideation in Healthy Participants
Richard J. Caselli et al.
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2015)
The influence of cerebrospinal fluid (CSF) biomarkers on clinical dementia evaluations
Jonathan Gooblar et al.
ALZHEIMERS & DEMENTIA (2015)
Ethics of genetic and biomarker test disclosures in neurodegenerative disease prevention trials
Scott Y. H. Kim et al.
NEUROLOGY (2015)
Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants
Kristin Harkins et al.
ALZHEIMERS RESEARCH & THERAPY (2015)
Confidentiality in preclinical Alzheimer disease studies When research and medical records meet
Jalayne J. Arias et al.
NEUROLOGY (2014)
Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association
Keith A. Johnson et al.
ALZHEIMERS & DEMENTIA (2013)
Disclosure of amyloid imaging results to research participants: Has the time come?
Jennifer H. Lingler et al.
ALZHEIMERS & DEMENTIA (2013)
Should we disclose amyloid imaging results to cognitively normal individuals?
Joshua D. Grill et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2013)
Amyloid imaging, risk disclosure and Alzheimer's disease: ethical and practical issues
J. Scott Roberts et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2013)
Current knowledge and future directions about the disclosure of dementia: A systematic review of the first decade of the 21st century
Perla Werner et al.
Alzheimers & Dementia (2012)
Accuracy of the Clinical Diagnosis of Alzheimer Disease at National Institute on Aging Alzheimer Disease Centers, 2005-2010
Thomas G. Beach et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2012)
Seeking Assent and Respecting Dissent in Dementia Research
Betty S. Black et al.
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY (2010)
Share Paper
